[1]ºúËÄÁú.11C-flumazenil PET¶Ôñ²ðïÔλÕï¶ÏµÄ¼ÛÖµ[J].¹ú¼Ê·ÅÉäҽѧºËҽѧÔÓÖ¾,2000,24(6):249-254.
¡¡HU Silong.The evaluation of 11C-flumazenil PET in the localisation of epileptic foci[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(6):249-254.

µã»÷¸´ÖÆ

¹¹C-flumazenil PET¶Ôñ²ðïÔλÕï¶ÏµÄ¼ÛÖµ(/HTML)

·ÖÏíµ½£º

²Î¿¼ÎÄÏ×/References:

[1] Loscher W.Basic aspects of epilepsy[J].Curr Opin Neurphysiol, 1993, 6:223-232.[2] Gloor P.Epilepsy:relationships between electrophysiology and intracellular mechanisms involving second messengers and gene expression[J].Can J Neurol Sci, 1989, 16:8-21.[3] Savic I, Widen L, Thorell JO, et al.Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy[J].Epilepsia, 1990, 31:724-730.[4] Savic I, Pauli S, Thorell JO, et al.In vivo demonstration of altered benzodiazepine receptor desity in patients with primary generalized epilepsy[J].J Neurol Neurosurg Psychiatr, 1994, 57:797-804.[5] Koepp MJ, Richardson MP, Brooks DJ, et al.Central benzodiazepine/gama-aminobutyric acid receptors in idiopathic generalized epilepsy:an [¹¹C] flumazenil positron emission tomography study[J].Epilepsia, 1997, 38:1089-1097.[6] Prevett MC, Lammertsma AA, Brooks DJ, et al.Bezodiazepine GABAA receptor binding during absence seizure[J].Epilesia, 1995, 36:592-599.[7] Koepp MJ, Richardson MP, Brooks DJ, et al.Cerebral benzodiazepine receptors in hippocampal sclerosis:An objective in vivo analysis[J].Brain, 1996, 119:1677-1687.[8] Savic I, Persson A, Roland P, et al.In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci[J].Lancet, 1988, 2:861-865.[9] Savic I, Svanborg E and Thorell JO.Cortical benzodiazepine receptor changes are related to frequency of partial seizure:A positron emission tomography study[J].Epilepsia, 1996, 37:236-244.[10] Koepp MJ, Richardson MP, Labbe C, et al.¹¹C-flumazenil PET, volumetric MRI, and quanitative pathology in mesial temporal lobe epilepsy[J].Neurology, 1997, 49:764-773.[11] Savic I, Thorell JO, and Roland P.[¹¹C] Flumazenil positron emission tomography visualizes frontal epileptogenic regions[J].Epilepsia, 1995, 36:1225-1232.[12] Richardson MP, Koepp MJ, Brooks DJ, et al.¹¹C-flumazenil PET in neocotical epilepsy[J].Neurology, 1998, 51:485-492.
[13] Richardson MP, Koepp MJ, Brooks DJ, et al.Benzodiazepine receptors in focal epilepsy with cortical dysgenesis:An ¹¹C-flumazenil PET study[J].Ann Neurol, 1996, 40:188-198.
[14] Savic I, Inguar M, and Stone-Elander S.Comparison of [¹¹C] flumazenil and ¹⁸F-FDG as PET markers of epileptic foci[J].J Neuro Neurosurg Psychiatry, 1993, 56:615-621.
[15] Henry TR, Frey KA, Sackellares JC, et al.In vivo cerebral metabolism and central benzodiazepine receptor binding in temporal lobe epilepsy[J].Neurology, 1993, 3:1998-2006.
[16] Szelies B, Weber-Luxenburger G, Pawlik G, et al.MRI-guied flumazenil-and FDG-PET in temporal lobe epilepsy[J].Neuroimage, 1996, 3:109-118.
[17] Debets RM, Sadzot B, Van Isset JW, et al.Is [¹¹C-] flumazeni1 PET superior to ¹⁸F-FDG PET and ¹²³I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?[J].J Neuro Neurosurg Psychiatry, 1997, 62:141-150.
[18] Koepp MJ, Labbe C, Richardson MP, et al.Regional hippocampal[¹¹C] flumazenil PET in temporal lobe epilpsy with unilateral and bilateral hippocampal sclerosis[J].Brain, 1997, 120:1865-1876.
[19] Ryvlin P, Bouvard S, Bars L, et al.Clinical utility of flumazenil PET versus[¹⁸F] fluorodeoxyglucose PET and MRI in refractory partial epilepsy[J].Brain, 1998, 121:2067-2081.
[20] Juhasz C, Nagy F, Muzik O, et al.[¹¹C] Flumazenil PET in patients with epilepsy with dual pathology[J].Epilepsia, 1999, 40:566-574.